Name: Elicio Therapeutics, Inc. (ELTX) Balance Sheet
Creator: FinSpry

Elicio Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Elicio Therapeutics, Inc. (ELTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	17.62	12.89	6.16	88.76	14.97
Cash & Short-Term Investments	17.62	12.89	6.16	88.76	14.97
Accounts Receivable	0.00	0.00	0.00	0.81	5.35
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.08	0.17	4.31	3.68	0.17
Total Current Assets	20.69	16.35	10.72	91.25	15.45
Non-Current Assets
Property, Plant & Equipment (Net)	6.19	7.28	8.50	4.44	1.02
Long-Term Investments	0.70	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.60	0.69	0.62	0.11	3.18
Total Non-Current Assets	7.49	10.80	11.95	5.27	5.05
Total Assets	28.18	27.15	22.66	96.51	19.66
Current Liabilities
Accounts Payable	1.04	4.37	4.74	7.93	1.65
Short-Term Debt	0.90	0.00	0.00	11.80	0.00
Accrued Liabilities	6.10	1.91	0.44	1.25	1.22
Deferred Revenue	1.17	0.00	0.00	0.00	0.00
Other Current Liabilities	8.42	0.03	1.49	0.11	39.22
Total Current Liabilities	11.52	9.76	6.87	11.30	3.31
Non-Current Liabilities
Long-Term Debt	25.14	6.01	6.79	3.71	4.48
Other Non-Current Liabilities	2.83	0.01	0.09	0.03	0.00
Total Non-Current Liabilities	27.97	6.02	14.38	3.71	30.35
Total Liabilities	39.49	15.77	21.24	15.01	3.31
Stockholders' Equity
Common Stock	0.11	0.10	0.00	0.17	0.13
Retained Earnings	-194.10	-142.20	-107.01	-215.24	-52.40
Accumulated Other Comprehensive Income	-0.18	-0.20	0.00	0.00	-0.21
Treasury Stock	0.15	0.15	0.00	0.00	-1.85
Additional Paid-in Capital	183.00	153.83	4.86	296.45	72.14
Shares Outstanding	11.03	9.60	8.73	8.73	0.00
Total Stockholders' Equity	-11.31	11.37	-102.15	81.51	16.35
Total Liabilities & Equity	28.18	27.15	22.66	96.51	47.35